Curcumin sensitizes pancreatic cancer cells to gemcitabine by attenuating PRC2 subunit EZH2, and the lncRNA PVT1 expression-Reference-Cited by-同舟云学术

Curcumin sensitizes pancreatic cancer cells to gemcitabine by attenuating PRC2 subunit EZH2, and the lncRNA PVT1 expression

Published:2017-07-17 Issue:10 Volume:38 Page:1036-1046
ISSN:0143-3334
Container-title:Carcinogenesis
language:en
Short-container-title:

Author:

Yoshida Kazuhiro¹,Toden Shusuke¹,Ravindranathan Preethi¹,Han Haiyong²,Goel Ajay¹

Affiliation:

1. Center for Gastrointestinal Research, Center for Translational Genomics and Oncology, Baylor Scott and White Research Institute and Charles A. Sammons Cancer Center, Baylor University Medical Center, Dallas, TX 75246, USA and

2. Translational Genomics Research Institute, Phoenix, AZ 85004, USA

Funder

National Cancer Institute

Cancer Prevention and Research Institute of Texas

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,General Medicine

Link

http://academic.oup.com/carcin/article-pdf/38/10/1036/24346389/bgx065.pdf

Reference52 articles.

1. Cancer statistics, 2015;Siegel;CA. Cancer J. Clin,(2015)

2. Expression and localization of human multidrug resistance protein (ABCC) family members in pancreatic carcinoma;König;Int. J. Cancer,(2005)

3. MUC1 induces drug resistance in pancreatic cancer cells via upregulation of multidrug resistance genes;Nath;Oncogenesis,(2013)

4. Pancreatic cancer: understanding and overcoming chemoresistance;Wang;Nat. Rev. Gastroenterol. Hepatol,(2011)

5. Molecular mechanisms involved in the synergistic interaction of the EZH2 inhibitor 3-deazaneplanocin A with gemcitabine in pancreatic cancer cells;Avan;Mol. Cancer Ther,(2012)

Cited by 169 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Curcumin Inhibits the Development of Pancreatic Cancer by Targeting the circ_0079440/miR-522-3p/EIF4A1 Pathway;Cell Biochemistry and Biophysics;2024-08-05

2. lncRNAs: New players of cancer drug resistance via targeting ABC transporters;IUBMB Life;2024-08

3. The LAMB3-EGFR signaling pathway mediates synergistic Anti-Cancer effects of berberine and emodin in Pancreatic cancer;Biochemical Pharmacology;2024-08

4. The Bright Side of Curcumin: A Narrative Review of Its Therapeutic Potential in Cancer Management;Cancers;2024-07-18

5. Curcumin synergistically enhances the efficacy of gemcitabine against gemcitabine-resistant cholangiocarcinoma via the targeting LAT2/glutamine pathway;Scientific Reports;2024-07-11